REPORT ID 6238

EMEA (Europe, Middle East and Africa) Allergy Immunotherapies Market Report 2017

Publish Date
25-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Allergy Immunotherapies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Allergy Immunotherapies for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Allergy Immunotherapies market competition by top manufacturers/players, with Allergy Immunotherapies sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    ALK Abello
    Allergy Therapeutics
    Circassia
    DBV Technologies
    Stallergenes Greer
    Merck KGaA (Allergopharma)
    HAL Allergy Group (Netherlands)
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Subcutaneous Immunotherapy
    Sublingual Immunotherapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Allergic Rhinitis
    Allergic Asthma
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Allergy Immunotherapies Market Report 2017
1 Allergy Immunotherapies Overview
    1.1 Product Overview and Scope of Allergy Immunotherapies
    1.2 Classification of Allergy Immunotherapies
        1.2.1 EMEA Allergy Immunotherapies Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Allergy Immunotherapies Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Subcutaneous Immunotherapy
        1.2.4 Sublingual Immunotherapy
    1.3 EMEA Allergy Immunotherapies Market by Application/End Users
        1.3.1 EMEA Allergy Immunotherapies Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Allergic Rhinitis
        1.3.3 Allergic Asthma
        1.3.4 Other
    1.4 EMEA Allergy Immunotherapies Market by Region
        1.4.1 EMEA Allergy Immunotherapies Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Allergy Immunotherapies (2012-2022)
        1.5.1 EMEA Allergy Immunotherapies Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Allergy Immunotherapies Revenue and Growth Rate (2012-2022)

2 EMEA Allergy Immunotherapies Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Allergy Immunotherapies Market Competition by Players/Manufacturers
        2.1.1 EMEA Allergy Immunotherapies Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Allergy Immunotherapies Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Allergy Immunotherapies Sale Price by Players (2012-2017)
    2.2 EMEA Allergy Immunotherapies (Volume and Value) by Type/Product Category
        2.2.1 EMEA Allergy Immunotherapies Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Allergy Immunotherapies Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Allergy Immunotherapies Sale Price by Type (2012-2017)
    2.3 EMEA Allergy Immunotherapies (Volume) by Application
    2.4 EMEA Allergy Immunotherapies (Volume and Value) by Region
        2.4.1 EMEA Allergy Immunotherapies Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Allergy Immunotherapies Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Allergy Immunotherapies Sales Price by Region (2012-2017)

3 Europe Allergy Immunotherapies (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Allergy Immunotherapies Sales and Value (2012-2017)
        3.1.1 Europe Allergy Immunotherapies Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Allergy Immunotherapies Revenue and Growth Rate (2012-2017)
    3.2 Europe Allergy Immunotherapies Sales and Market Share by Type
    3.3 Europe Allergy Immunotherapies Sales and Market Share by Application
    3.4 Europe Allergy Immunotherapies Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Allergy Immunotherapies Sales Volume by Countries (2012-2017)
        3.4.2 Europe Allergy Immunotherapies Revenue by Countries (2012-2017)
        3.4.3 Germany Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        3.4.4 France Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        3.4.5 UK Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        3.4.6 Russia Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        3.4.7 Italy Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Allergy Immunotherapies Sales and Growth Rate (2012-2017)

4 Middle East Allergy Immunotherapies (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Allergy Immunotherapies Sales and Value (2012-2017)
        4.1.1 Middle East Allergy Immunotherapies Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Allergy Immunotherapies Revenue and Growth Rate (2012-2017)
    4.2 Middle East Allergy Immunotherapies Sales and Market Share by Type
    4.3 Middle East Allergy Immunotherapies Sales and Market Share by Application
    4.4 Middle East Allergy Immunotherapies Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Allergy Immunotherapies Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Allergy Immunotherapies Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        4.4.4 Israel Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        4.4.5 UAE Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        4.4.6 Iran Allergy Immunotherapies Sales and Growth Rate (2012-2017)

5 Africa Allergy Immunotherapies (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Allergy Immunotherapies Sales and Value (2012-2017)
        5.1.1 Africa Allergy Immunotherapies Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Allergy Immunotherapies Revenue and Growth Rate (2012-2017)
    5.2 Africa Allergy Immunotherapies Sales and Market Share by Type
    5.3 Africa Allergy Immunotherapies Sales and Market Share by Application
    5.4 Africa Allergy Immunotherapies Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Allergy Immunotherapies Sales Volume by Countries (2012-2017)
        5.4.2 Africa Allergy Immunotherapies Revenue by Countries (2012-2017)
        5.4.3 South Africa Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Allergy Immunotherapies Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Allergy Immunotherapies Sales and Growth Rate (2012-2017)

6 EMEA Allergy Immunotherapies Manufacturers/Players Profiles and Sales Data
    6.1 ALK Abello
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Allergy Immunotherapies Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 ALK Abello Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Allergy Therapeutics
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Allergy Immunotherapies Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Allergy Therapeutics Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Circassia
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Allergy Immunotherapies Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Circassia Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 DBV Technologies
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Allergy Immunotherapies Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 DBV Technologies Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Stallergenes Greer
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Allergy Immunotherapies Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Stallergenes Greer Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Merck KGaA (Allergopharma)
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Allergy Immunotherapies Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Merck KGaA (Allergopharma) Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 HAL Allergy Group (Netherlands)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Allergy Immunotherapies Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Allergy Immunotherapies Manufacturing Cost Analysis
    7.1 Allergy Immunotherapies Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Allergy Immunotherapies

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Allergy Immunotherapies Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Allergy Immunotherapies Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Allergy Immunotherapies Market Forecast (2017-2022)
    11.1 EMEA Allergy Immunotherapies Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Allergy Immunotherapies Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Allergy Immunotherapies Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Allergy Immunotherapies Price and Trend Forecast (2017-2022)
    11.2 EMEA Allergy Immunotherapies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Allergy Immunotherapies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Allergy Immunotherapies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Allergy Immunotherapies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Allergy Immunotherapies Sales Forecast by Type (2017-2022)
    11.7 EMEA Allergy Immunotherapies Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer